跳至主要内容
临床试验/NCT05519813
NCT05519813Unknown4 期

Effects of Pioglitazone Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients With Hyperandrogenemia.

Bing He1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年1月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
Changes in sex hormone binding globulin (SHBG)

研究概览

简要总结

To study the effects of pioglitazone combined with metformin and metformin on gonadal and metabolic profiles in PCOS patients with BMI < 24 in China. 60 cases of nonobese PCOS patients were collected from Shengjing hospital. The intervention period was 3 months after intervention with met or met + ph. To evaluate the improvement of met or met + ph in the treatment of hyperandremia, glucose metabolism, BMI, waist circumference, menstruation, hairiness and acne in PCOS patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Females 18 years to 40 years of age Diagnosed as PCOS by the 2003 Rotterdam criteria
  • BMI<24 kg/m2
  • No pregnant plan in recent 6 months
  • Written consent for participation in the study

排除标准

  • type 1 or type 2 diabetes mellitus
  • Subjects have other endocrine diseases, such as adrenal hyperplasias or tumor, androgen-secreting tumors, Cushing's syndrome, thyroid diseases, and hyperprolactinemia
  • Diagnosed with or have a family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Serious systemic disease or malignant tumor
  • History of pancreatitis (chronic, acute or recurrent)
  • Body weight change ≥10% at 3 months before treatment
  • Used oral contraceptives or sex hormone drugs in the past 1 month
  • Used oral glucocorticoids in the past 1 month
  • Substance (alcohol or drug) abuse or dependence within 3 months
  • Heavy smokers (smokers who smoke 20 or more cigarettes a day) or heavy drinkers (>10g/d)
  • Subjects have a severe systemic disease, such as cardiovascular system, Renal impairment (eGFR<60ml/min/1.73m2)
  • Increase of transaminases up to < 2.5 times of upper limit of normal value
  • Have a history of thromboembolic disease or thrombotic tendency
  • Subjects in pregnant or lactating or within 1 year after delivery
  • Subjects have an allergic history to the drugs used in the study
  • Subjects have participated in other clinical researches of medicine within
  • 1 month prior to randomization
  • Use of metformin, pioglitazone, or pioglitazone combined with metformin within 30 days before screening

研究组 & 干预措施

Use Metformin for 3 months to treat PCOS

Experimental

Active Comparator: Metformin (BMI<24) Subjects: PCOS patients whoseBMI<24 Drug: Glucophage Generic name: Metformin Dosage form: 500mg Dosage: 1500-2000mg/day Frequency: 500mg three times a day/1000mg twice a day Duration: 3 months

干预措施: Metformin (Drug)

Use Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets for 3 months to treat PCOS

Experimental

Active Comparator: Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets (BMI<24) Subjects: PCOS patients whoseBMI<24 Drug: Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets Generic name: Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets Dosage form: 15mg/500mg Dosage: 2 tablets/day Frequency: one tablet twice a day Duration: 3 months

干预措施: Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets (Drug)

结局指标

主要结局

Changes in sex hormone binding globulin (SHBG)

时间窗: 12 weeks

Changes in sex hormone binding globulin (SHBG)

次要结局

  • Changes in frequency of menstrual cycle(12 weeks)
  • Changes in follicle stimulating hormone (FSH)(12 weeks)
  • Change in Acne severity score(12 weeks)
  • Change in waist circumference(WC)(12 weeks)
  • Changes in Luteinizing Hormone (LH)(12 weeks)
  • Changes in prolactin (PRL)(12 weeks)
  • Changes in free testosterone (FT)(12 weeks)
  • Changes in total testosterone (TT)(12 weeks)
  • Changes in anti-müllerian hormone (AMH)(12 weeks)
  • Changes in dehydroepiandrosterone sulfate (DHEAS)(12 weeks)
  • Changes in progesterone (Prog)(12 weeks)
  • Changes in Blood Glucose and Insulin During the oral glucose tolerance test (OGTT)(12 weeks)
  • Change in Ferriman-Gallwey score(12 weeks)

研究者

发起方
Bing He
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Bing He

Professor

Shengjing Hospital

研究点 (1)

Loading locations...

相似试验